Featured Research

from universities, journals, and other organizations

Two studies on the use of breast MRI

Date:
November 18, 2013
Source:
The JAMA Network Journals
Summary:
The overall use of breast magnetic resonance imaging has increased, with the procedure most commonly used for diagnostic evaluations and screenings, according to a study.

Two studies have been released on the topic of MRIuse in breast cancer treatment.

Study Finds Use of Breast MRI in Women Increasing

The overall use of breast magnetic resonance imaging has increased, with the procedure most commonly used for diagnostic evaluations and screenings, according to a study published by JAMA Internal Medicine, a JAMA Network publication.

While breast MRI is being used increasingly, its sensitivity leads to higher false-positive rates and it is also more expensive. Guidelines from the American Cancer Society (ACS) indicate that breast MRI should be used to screen asymptomatic women at high-risk for breast cancer if they are known carriers of the BRCA gene mutation; first-degree relatives of a known BRCA gene mutation carrier who are themselves untested; or a women with more than a 20 percent lifetime risk of breast cancer, according to the study background.

Karen J. Wernli, Ph.D., of the Group Health Research Institute, Seattle, and colleagues examined the patterns of breast MRI in U.S. community practice from 2005 through 2009 with data collected from five national Breast Cancer Surveillance Consortium registries.

Study results show the overall rate of breast MRI nearly tripled from 4.2 to 11.5 examinations per 1,000 women from 2005 through 2009. The procedure was most commonly used for diagnostic evaluation (40.3 percent), followed by screening (31.7 percent). Women who underwent screening breast MRI were more likely to be younger than 50 years old, white, nulliparous (never had a baby), have a personal history of breast cancer, a family history of breast cancer and extremely dense breast tissue.

Study findings also indicate that the proportion of women screened with breast MRI at high lifetime risk for breast cancer increased from 9 percent in 2005 to 29 percent in 2009. The researchers also note that during the study period, the most common use of breast MRI was for diagnostic evaluation of a non-MRI finding.

"Our findings suggest that there have been improvements in appropriate use of breast MRI, with a smaller proportion of examinations performed for further evaluation of abnormal mammogram results and symptomatic patients, and more breast MRI performed for screening of women at high risk," the authors conclude.

Breast MRI Use Increased Then Stabilized Over Past Decade

The use of breast magnetic resonance imaging (MRI) increased in the decade after 2001 before eventually stabilizing, especially for screening and surveillance of women with a family or personal history of breast cancer, according to a study by Natasha K. Stout, Ph.D., of the Harvard Medical School and the Harvard Pilgrim Health Care Institute, Boston, and colleagues.

Although breast MRI is more sensitive than mammography in detecting breast cancer, cost and little evidence regarding the mortality benefits have limited recommendations for its use, the study background notes.

Between 2000 and 2001, researchers studied 10,518 women (ages 20 and older) who were enrolled in a health plan for at least one year and had at least one breast MRI at a multispecialty group medical practice in New England. Breast MRI counts and breast cancer risk status, as well as the reason for testing (screening, diagnostic evaluation, staging or treatment, or surveillance) were obtained.

According to study results, breast MRI increased from 2000 (6.5 examinations per 10,000 women) to 2009 (130.7 exams per 10,000 women), with the greatest increase in use for screening and surveillance. By 2011, use declined then stabilized (104.8 exams per 10,000 women). Screening and surveillance accounted for 57.6 percent of MRI use by 2011. Of the women, 30.1 percent had a claims-document personal history, 51.7 percent a family history of breast cancer, and 3.5 percent of women had a documented genetic mutation.

Researchers noted that in a subset of women with electronic medical records who received screening or surveillance MRIs, only 21 percent had evidence of meeting American Cancer Society criteria for breast MRI. Only 48.4 percent of women with documented genetic mutations received breast MRI screening.

"Understanding who is receiving breast MRI and the downstream consequences of this use should be a high research priority to ensure that the limited health care funds available are used to wisely maximize population health," the authors conclude.


Story Source:

The above story is based on materials provided by The JAMA Network Journals. Note: Materials may be edited for content and length.


Journal References:

  1. Natasha K. Stout, Larissa Nekhlyudov, Lingling Li, Elisabeth S. Malin, Dennis Ross-Degnan, Diana S. M. Buist, Marjorie A. Rosenberg, Marina Alfisher, Suzanne W. Fletcher. Rapid Increase in Breast Magnetic Resonance Imaging Use. JAMA Internal Medicine, 2013; DOI: 10.1001/jamainternmed.2013.11958
  2. Wernli et al. Patterns of Breast Magnetic Resonance Imaging Use. JAMA Internal Medicine, November 2013

Cite This Page:

The JAMA Network Journals. "Two studies on the use of breast MRI." ScienceDaily. ScienceDaily, 18 November 2013. <www.sciencedaily.com/releases/2013/11/131118162811.htm>.
The JAMA Network Journals. (2013, November 18). Two studies on the use of breast MRI. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2013/11/131118162811.htm
The JAMA Network Journals. "Two studies on the use of breast MRI." ScienceDaily. www.sciencedaily.com/releases/2013/11/131118162811.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Nigeria Ups Ebola Stakes on 1st Death

Nigeria Ups Ebola Stakes on 1st Death

Reuters - Business Video Online (July 29, 2014) Nigerian authorities have shut and quarantined a Lagos hospital where a Liberian man died of the Ebola virus, the first recorded case of the highly-infectious disease in Africa's most populous economy. David Pollard reports Video provided by Reuters
Powered by NewsLook.com
Running 5 Minutes A Day Might Add Years To Your Life

Running 5 Minutes A Day Might Add Years To Your Life

Newsy (July 29, 2014) According to a new study, just five minutes of running or jogging a day could add years to your life. Video provided by Newsy
Powered by NewsLook.com
Ebola Outbreak Poses Little Threat To U.S.: CDC

Ebola Outbreak Poses Little Threat To U.S.: CDC

Newsy (July 29, 2014) The Ebola outbreak in West Africa poses little threat to Americans, according to officials with the Centers for Disease Control and Prevention. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins